Oncology
Video: Head-to-head comparison of overall survival in subgroups of patients with metastatic castration-sensitive prostate cancer initiating apalutamide or abiraterone acetate - A real-world study
Connect with us
Connect with us
Would you like to clear and leave your conversation? Message history will be lost.